Content will be added shortly.
| Sl No. | Title | Authors | Journal Name | Publication Year |
|---|---|---|---|---|
| 16 | RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target | Thomas P, Pranatharthi A, Ross C, Srivastava S | J Exp Clin Cancer Res | 2019 |
| 17 | Cystic Neutrophilic Granulomatous Mastitis: A Clinicopathological Study With 16s rRNA Sequencing for the Detection of Corynebacteria in Formalin-Fixed Paraffin-Embedded Tissue | Naik MA, Korlimarla A, Shetty ST, Fernandes AM, Pai SA | Int J Surg Pathol | 2019 |
| 18 | Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia | Ganesan S, Palani HK, Lakshmanan V, Balasundaram N, Alex AA, David S, Venkatraman A, Korula A, George B, Balasubramanian P, Palakodeti D, Vyas N, Mathews V | Cell Death Dis | 2019 |
| 19 | Progress in psycho-oncology with special reference to developing countries | Murthy RS, Alexander A | Curr Opin Psychiatry | 2019 |
| 20 | The impact of breast cancer on the patient and the family in Indian perspective | Alexander A, Kaluve R, Prabhu JS, Korlimarla A, Srinath BS, Manjunath S, Patil S, Gopinath KS, Sridhar TS | Indian J Palliat Care | 2019 |
| 21 | Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease | Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS | Translational Oncology | 2017 |
| 22 | HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells | Desai K, Aiyappa R, Prabhu JS, Nair MG, Lawrence PV, Korlimarla A, CE Anupama, Alexander A, Kaluve RS, Manjunath S, Correa M, Srinath BS, Patil S, Kalamdani A, Prasad M, Sridhar TS | Tumour Biology | 2017 |
| 23 | High expression of integrin beta6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers | Desai K, Nair MG, Prabhu JS, Vinod A, Korlimarla A, Rajarajan S, Aiyappa R, Kaluve RS, Alexander A, Hari PS, Mukherjee G, Kumar RV, Manjunath S, Correa M, Srinath BS, Patil S, Prasad MS, Gopinath KS, Rao RN, Violette SM, Weinreb PH, Sridhar TS | Cancer Medicine | 2016 |
| 24 | Data on alteration of hormone and growth factor receptor profiles over progressive passages of breast cancer cell lines representing different clinical subtypes | Nair MG, Desai K, Prabhu JS, Hari PS, Remacle J, Sridhar TS | Data in Brief | 2016 |
| 25 | Beta3 integrin promotes chemoresistance to epirubicin in MDA-MB-231 through repression of the pro-apoptotic protein, BAD | Nair MG, Desai K, Prabhu JS, Hari PS, Remacle J, Sridhar TS | Experimental Cell Research | 2016 |
| 26 | Analysis of Clinico-Pathological Characteristics of Indian Breast CancersShows Conservation of Specific Features in the Hormone Receptor Sub-Types | Mukherjee G, Lakshmaiah KC, Vijayakumar M, Prabhu JS, Telikicherla D, Sridhar TS, Kumar RV | Journal of Integrative Oncology | 2016 |
| 27 | Cancer research in India: national priorities, global results. | Sullivan R, Badwe RA, Rath GK, Pramesh CS, Shanta V, Digumarti R, D'Cruz A, Sharma SC, Viswanath L, Shet A, Vijayakumar M, Lewison G, Chandy M, Kulkarni P, Bardia MR, Kumar S, Sarin R, Sebastian P, Dhillon PK, Rajaraman P, Trimble EL, Aggarwal A, Vijaykum | Lancet Oncol | 2014 |
| 28 | A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors | Prabhu JS, Korlimarla A, Desai K, Alexander A, Raghavan R, Anupama C, Dendukuri N, Manjunath S, Correa M, Raman N, Kalamdani A, Prasad M, Gopinath KS, Srinath BS, Sridhar TS | Journal of Cancer | 2014 |
| 29 | Separate quality-control measures are necessary for estimation of RNA and methylated DNA from formalin-fixed, paraffin-embedded specimens by quantitative PCR | Korlimarla A, Prabhu JS, Anupama CE, Remacle J, Wahi K, Sridhar TS | J Mol Diagn | 2014 |
| 30 | Identification of a non-canonical nuclear localization signal (NLS) in BRCA1 that could mediate nuclear localization of splice variants lacking the classical NLS | Korlimarla A, Bhandary L, Prabhu JS, Shankar H, Sankaranarayanan H, Kumar P, Remacle J, Natarajan D, Sridhar TS | Cellular & Molecular Biology Letters | 2013 |